Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism / Ilenia Pirola, Carlo Cappelli, Andrea Delbarba, Tiziano Scalvini, Barbara Agosti, Deodato Assanelli, Antonio Bonetti, Maurizio Castellano. - (Fertility and Sterility 94 (2010) 6 (November); p. 1-3).
- PMID: 20416868.
- DOI: 10.1016/j.fertnstert.2010.03.042

Abstract

Objective: To report a case of hypogonadotropic hypogonadism due to the chronic abuse of anabolic steroids purchased over the Internet.

Design: Case report.
Setting: Endocrinology unit of the University of Brescia.
Patient(s): A 34-year-old man.
Intervention(s): A single dose (100 μg) of triptorelin (triptorelin test).

Main outcome measure(s): Clinical symptoms, androgen normalization, levels of serum testosterone, follicle-stimulating hormone, and luteinizing hormone.

Result(s): Within 1 month, the patient's serum testosterone was in the normal range, and he reported a return to normal energy and libido.

Conclusion(s): The World Anti-Doping Code has proved to be a very powerful and effective tool in the harmonization of antidoping efforts worldwide, but it is insufficient to combat this illegal phenomenon. To tackle the serious side effects caused by doping we believe that it is necessary to increase monitoring and adopt severe sanctions, particularly with regard to Internet sites.

In February 2020 the Athletics Integrity Unit (AIU) of World Athletics has reported an anti-doping rule violation against the Indian Athlete Kiranjit Kaur after her sample tested positive for the prohibited substance Enobosarm (ostarine). After notification the Athlete gave a prompt admission, waived her right for a hearing, accepted a provisional suspension and the sanction proposed by by AIU.

The Athlete explained that she underwent medical treatment for her conditions and had used medications. The AIU finds that the Athlete failed to explain sufficiently the presence of the prohibited substance in her sample.

Therefore the AIU decides on 27 May 2020 to impose a 4 year period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 15 December 2020.

In March 2020 the Athletics Integrity Unit (AIU) of World Athletics has reported an anti-doping rule violation against the Kenyan Athlete Mikel Kiprotich Mutai after his sample tested positive for the prohibited substances 19-norandrosterone and 19-noretiocholanolone (Nandrolone).

After notification the Athlete admitted the violation, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by by AIU. The AIU did not accept the Athlete's explanation that he only had used a medication and a supplement.

Therefore the AIU decides on 26 May 2020 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 20 March 2020.

In September 2019 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete Graeme Thompson after his sample tested positive for the prohibited substances Clenbuterol and Tamoxifen. After notification the Athlete admitted the violation, waived his right for a hearing, accepted the provisional suspension and the sanction proposed by CCES.

The Athlete denied the intentional use of the substances and asserted that the positive test was the result of contaminated supplements he had used. Analysis in the Montreal Lab of these supplements confirmed the presence of these substances in the packages.

CCES accepts that the violation was not intentional and issued in May 2020 an amended Notification for the imposition of a reduced sanction. Here CCES considers that the substances were not listed on the labels of the supplements in question and neither an internet search would reveal the presence of these substances in these supplements. Further the Montreal Lab confirmed that the concentration of Clenbuterol found in the sample was consistent with the level detected in the Athlete's supplements.

Therefore the CCES decides on 29 May 2020 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 10 October 2019.

In April 2020 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the snowboard athlete Matt Hamilton after his sample tested positive for the prohibited substance GW501516.

After notification a provisional suspension was ordered and the Athlete requested an extention of the stipulated deadlines. However he failed hereafter to respond to the asserted violation and he ceased his engagement in the results management process.

Because the Athlete failed to dispute the asserted violation within the deadline under the Rules follows that the Athlete is deemed to have admitted the violation, to have waived his right for a hearing and to have accepted the proposed consequences.

Therefore the CCES decides on 28 May 2020 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 8 April 2020.

COVID-19 : Athlete Q&A / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020

The World Anti-Doping Agency (WADA) has published a Question and Answer (Q&A) document related to anti-doping and COVID-19, which is an update to the document that the Agency published on 23 March 2020. Once again, it was developed in consultation with WADA’s Athlete Committee.

The updated Q&A covers matters such as:

- Testing during COVID-19
- Minimizing the risk of contracting or transmitting the virus
- Filing of whereabouts information
- Validating Therapeutic Use Exemptions
- Maintaining the integrity of the global anti-doping system
- Refusing to comply with testers at this time
- Confidence in the anti-doping system

WADA will continue to liaise with athletes and Anti-Doping Organizations in the interest of publishing updates regarding the Agency’s response to COVID-19 as the situation evolves.

iNADO Update (2020) 5 (25 Mai)
Institute of National Anti-Doping Organisations (iNADO)

Contents:

From the iNADO Community
- A New Era for Sports Integrity in Australia
- Upcoming Webinar
- Anti-Doping Switzerland to expand Investigative Activities
- Opinion: A Safe and Clean Return to Sport after Covid-19
Testing
- Testing during Covid-19: Unusual Challenges call for unusual Measures
- How to collect Evidence in I&I: A Summary of Got Ethics Webinar
- Informed Sport: Providing a harmonised Approach to Supplements Testing
Research
- The Implementation and Effect of the Athlete Biological Passport
WADA
- 2021 Code Implementation Support Programme goes Online
- Updated Covid-19 Guidelines for Anti-Doping Organisations
- WADA opens Nomination Process for 2021 Standing Committee Member Vacancies
Sport and National Anti-Doping Rules
- FEI Consultation to adapt Anti-Doping Rules
- Milestone for Anti-Doping Law in Germany
- New at the Anti-Doping Knowledge Center

In December 2019 the International Tennis Federation has reported an anti-doping rule violation against the Peruvian tennis player Arklon Huertas del Pino after his sample tested positive for the prohibited substance Cannabis in a concentration above the WADA threshold.
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the ITF Independent Tribunal.

The Athlete gave a prompt admission, denied the intentional use of the substance and requested for a reduced sanction. He explained that prior to the competition and unrelated to sport he had smoked recreational a large joint and Cannabis cigarettes. He asserted that there are grounds for No Significant Fault or Negligence since personal use of Cannabis in Peru is legal, he had limited anti-doping education and he believed the substance would only last in is system for a few hours.

The Tribunal accepts that the violation was not intentional but finds that there are no grounds to reduce the sanction because of No Significant Fault or Negligence. Considering the Athlete's conduct in this case the Tribunal deems that he had acted with indifference and negligence as a professional tennis player.

Therefore the ITF Independent Tribunal decides on 15 May 2020 to impose a 2 year period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 24 October 2019.

In August 2014 the National Anti Doping Agency of Germany (NADA) has reported an anti-doping rule violation against the cyclist Erik D. after his sample tested positive for the prohibited substance Testosterone. After notification a provisional suspension was ordered. The case was settled by the the German Institution of Arbitration (DIS).

The Athlete admitted the violation and denied the intentional use of the substance. He explained with evidence the he had used Testogel prescribed by his doctor as treatment for his condition. He became aware in April 2014 that his medication contained a prohibited substance but after the Notification in August 2014 he made the application for a TUE. He stated that he had already stopped using the medication 3 weeks before the Doping Control and didn’t mention his medication in question on the Doping Control Form.

NADA argued that as an amateur cyclist the Athlete only needed a valid doctor's certificate and not a TUE for the use of the prescribed medication. NADA contended that he committed an anti-doping rule violation because he failed to have the necessary certificate when tested while he was aware that his medication contained a prohibited substance. Further NADA contended that the concentration of Testosterone found in the Athlete’s sample showed that he had used the medication much longer as claimed and he failed to mention his medication on the Doping Control Form.

The Tribunal deems that the presence of a prohibited substance had been established in the Athlete’s sample and accordingly that he had committed an anti-doping rule violation.
The Tribunal considers the Athlete’s conduct in this case and concludes that there are no grounds for a reduced sanction. The Tribunal establishes that the Athlete was aware since April 2014 that he had used a prescribed medication that contained a prohibited substance. Nevertheless he participated in 14 competitions, he had not a valid doctor’s certificate nor mentioned his medication on the Doping Control Form.

Therefore the DIS Tribunal decides on 11 May 2015 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension

In 2014 the National Anti Doping Agency of Germany has reported an anti-doping rule violation against the baseball player Kyle W. after his sample tested posititve for the prohibited substance Ephedrine. The case was settled by the Tribunal of the German Institution of Arbitration (DIS).

After notification the Athlete failed to respond to any of the communications submitted to him. It appeared that the Athlete had moved to a new address where the submitted letters and e-mails were ignored by the Athlete.

The Tribunal finds that in the Athlete's sample the presence of a prohibited substance has been established and accordingly that he committed an anti-doping rule violation. The Tribunale deems that the Athlete was duly notified, failed to respond and failed to explain how the prohibited substance entered his system.

Therefore the DIS Tribunal decides on 17 June 2015 to impose a 2 year period of ineligibility on the Athlete starting on the date of the decision, i.e. on 17 June 2015.